한글목차

세계의 의약품 수탁제조 시장은 2025년에 2,322억 8,000만 달러로 추정되며, 2032년에는 4,500억 7,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 9.9%로 성장할 전망입니다.

도표. 의약품 수탁제조 시장 지역별 점유율(%)(2025년)

세계 의약품 수탁제조 시장은 지난 수년간 꾸준한 성장세를 보이고 있습니다. 의약품 수탁제조은 의약품의 제조, 포장, 검사 등 특정 의약품 공정을 의약품 수탁제조기관(CMO)으로 알려진 제3자 기업에 아웃소싱하는 것을 말합니다. 제조 비용을 절감하고 핵심 역량에 집중해야 할 필요성이 커지면서 제약사들이 제조 요건을 CMO에 아웃소싱하는 주요 요인이 되고 있습니다. 또한 특허 만료로 인한 지속적인 손실, 제네릭 의약품에 대한 수요 증가, 의약품 개발 및 상업화 활동의 아웃소싱 증가 등은 향후 수년간 세계 의약품 수탁제조 시장의 성장을 더욱 촉진할 것으로 예상됩니다.

시장 역학

세계 의약품 수탁제조 시장의 성장을 주도하는 것은 심혈관 질환의 유병률 증가와 부정맥 위험이 높은 노년층 인구 증가입니다. 세계보건기구(WHO) 자료에 따르면 심혈관 질환은 전 세계 사망 원인 1위로 매년 1,700만 명 이상이 심장마비와 뇌졸중으로 인해 목숨을 잃고 있습니다. 또한 소형화와 배터리 수명 연장에 초점을 맞춘 기술 혁신으로 심박조율기 이식의 적응증이 확대되고 있습니다. 그러나 심박조율기 수술에 따른 높은 비용과 리드 결함 및 감염과 같은 기기 합병증 위험은 시장 성장을 저해하는 요인으로 작용할 수 있습니다.

본 조사의 주요 특징

• 세계의 의약품 수탁제조(CMO) 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 이 보고서는 다양한 부문에서 잠재적인 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 의약품 수탁제조 시장의 주요 기업을 프로파일링합니다.
• 주요 기업에는 Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., Celltrion 등이 포함됩니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 의약품 수탁제조 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 의약품 수탁제조 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 산업 분석

제4장 세계의 의약품 수탁제조 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 의약품 수탁제조 시장, 서비스 유형별, 2020-2032년(10억 달러)

• 서론
• 계약 제조 조직(CMO)
• API 제조
• 최종제형 제조
• 포장
• 임상시험수탁기관(CRO)
• Drug Discovery
• 전임상 연구
• 초기 단계 I-IIa
• 단계 IIa-III
• 단계 IIIb-IV
• 의료 코딩과 라이팅
• 모니터링
• 임상 데이터 관리
• 기타(프로토콜 개발 등)

제6장 세계의 의약품 수탁제조 시장, 분자 유형별, 2020-2032년(10억 달러)

• 서론
• 소분자
• 거대 분자

제7장 세계의 의약품 수탁제조 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • Lonza Group
  • Boehringer Ingelheim GmbH
  • Genpact Limited
  • Accenture plc
  • Quintiles Transnational Corporation
  • Baxter
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Pfizer, Inc.
  • The Almac Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd.
  • Covance, Inc.
  • Catalent, Inc.
  • Abbvie, Inc.
  • Celltrion

제9장 애널리스트의 권장사항

• 운명의 수레바퀴
• COM(Coherent Opportunity Map)

제10장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Contract Pharmaceutical Manufacturing Market is estimated to be valued at USD 232.28 Bn in 2025 and is expected to reach USD 450.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Figure. Contract Pharmaceutical Manufacturing Market Share (%), By Region 2025

The global contract pharmaceutical manufacturing market has been witnessing steady growth over the past few years. Contract pharmaceutical manufacturing refers to the outsourcing of certain pharmaceutical processes such as manufacturing, packaging, and testing of pharmaceutical drugs to a third party company known as contract manufacturing organizations (CMOs). The growing need to reduce manufacturing costs and focus on core competencies are some of the key factors driving pharmaceutical companies to outsource their production requirements to CMOs. In addition, continued patent cliff losses, rising demand for generic drugs, and increasing outsourcing of drug development and commercialization activities are further expected to support the growth of the global contract pharmaceutical manufacturing market in the coming years.

Market Dynamics:

The global contract pharmaceutical manufacturing market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by World Health Organization, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global contract pharmaceutical manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global contract pharmaceutical manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter , Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., and Celltrion.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global contract pharmaceutical manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract pharmaceutical manufacturing market.

Detailed Segmentation-

• By Service Type:
  • Contract Manufacturing Organization (CMO)
  • API Manufacturing
  • Final dosage form manufacturing
  • Packaging
  • Contract Research Organization (CRO)
  • Drug Discovery
  • Preclinical Studies
  • Early Phase I - IIa
  • Phase IIa - III
  • Phase IIIb - IV
  • Medical Coding and Writing
  • Monitoring
  • Clinical Data Management
  • Others (Protocol Development, etc.)
• By Molecule Type:
  • Small Molecule
  • Large Molecule
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Lonza Group
  • Boehringer Ingelheim GmbH
  • Genpact Limited
  • Accenture plc
  • Quintiles Transnational Corporation
  • Baxter
  • Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Pfizer, Inc.
  • The Almac Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd.
  • Covance, Inc.
  • Catalent, Inc.
  • Abbvie, Inc.
  • Celltrion

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Service Type
  • Market Snapshot, By Molecule Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Contract Pharmaceutical Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Contract Manufacturing Organization (CMO)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• API Manufacturing
• Final dosage form manufacturing
• Packaging
• Contract Research Organization (CRO)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Discovery
• Preclinical Studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical Coding and Writing
• Monitoring
• Clinical Data Management
• Others (Protocol Development, etc.)

6. Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Small Molecule
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Large Molecule
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contract Pharmaceutical Manufacturing Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Lonza Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Genpact Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Accenture plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Quintiles Transnational Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dr. Reddy's Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Aurobindo Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • The Almac Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Piramal Enterprises Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Catalent, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbvie, Inc.
  • Celltrion

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact